Active Substance |
Strength |
Form |
Acyclovir |
5% (Tubx10g) |
Cr.Ext.Us |
Alendronic acid |
70mg |
Tab |
Ambroxol HCl |
15mg/5ml (125ml Bottle) |
Syr Infant |
Ambroxol HCl |
30mg/5ml (125ml, 250ml Bottles) |
Syr |
Amikacin |
500mg/2ml |
Inj.Sol |
Amikacin |
1g/4ml |
Inj.Sol |
ApixabanUnder Development |
2.5mg/tab & 5mg/tab |
F.C.Tabs |
Atorvastatin |
20mg, 40mg |
F.C.Tab |
Azithromycin |
500mg/Vial |
Pd.Sol.Inf |
Azithromycin |
250mg, 500mg, 600mg |
F.C.Tab |
BrivaracetamUnder Development |
10mg/ml |
Sol.Inf |
BrivaracetamUnder Development |
10mg/ml |
Oral Solution |
Budesonide |
0.025% (Tubx30g, x50g, x100g) |
Cr.Ext.Us |
Budesonide |
100mcg/Dose (FLx10ml (200 Doses)) |
Naspr.Sus |
Butamirate Citrate |
7.5mg/5ml (200ml Bottle) |
Syr |
Caspofungin |
50mg, 70mg/Vial |
Pd.C.So.In |
Cefotaxime |
1g/Vial (IM, IV) |
Ps.Inj.Sol |
Ceftaroline FosamilUnder Development |
600mg/vial |
Pd.C.So.In |
Ceftazidime/ AvibactamUnder Development |
2 g/0.5 g |
Pd.C.So.In |
Ceftriaxone |
1g/Vial (IM, IV) |
Ps.Inj.Sol |
Products Search Results for ""
Active Substance |
Strength |
Form |
Acyclovir |
5% (Tubx10g) |
Cr.Ext.Us |
Alendronic acid |
70mg |
Tab |
Ambroxol HCl |
15mg/5ml (125ml Bottle) |
Syr Infant |
Ambroxol HCl |
30mg/5ml (125ml, 250ml Bottles) |
Syr |
Amikacin |
500mg/2ml |
Inj.Sol |
Amikacin |
1g/4ml |
Inj.Sol |
Apixaban |
2.5mg/tab & 5mg/tab |
F.C.Tabs |
Atorvastatin |
20mg, 40mg |
F.C.Tab |
Azithromycin |
500mg/Vial |
Pd.Sol.Inf |
Azithromycin |
250mg, 500mg, 600mg |
F.C.Tab |
Brivaracetam |
10mg/ml |
Sol.Inf |
Brivaracetam |
10mg/ml |
Oral Solution |
Budesonide |
0.025% (Tubx30g, x50g, x100g) |
Cr.Ext.Us |
Budesonide |
100mcg/Dose (FLx10ml (200 Doses)) |
Naspr.Sus |
Butamirate Citrate |
7.5mg/5ml (200ml Bottle) |
Syr |
Caspofungin |
50mg, 70mg/Vial |
Pd.C.So.In |
Cefotaxime |
1g/Vial (IM, IV) |
Ps.Inj.Sol |
Ceftaroline Fosamil |
600mg/vial |
Pd.C.So.In |
Ceftazidime/ Avibactam |
2 g/0.5 g |
Pd.C.So.In |
Ceftriaxone |
1g/Vial (IM, IV) |
Ps.Inj.Sol |
Active Substance |
Strength |
Form |
Market Availability |
Acyclovir |
5% (Tubx10g) |
Cr.Ext.Us |
Selected Markets |
Alendronic acid |
70mg |
Tab |
Selected Markets |
Ambroxol HCl |
15mg/5ml (125ml Bottle) |
Syr Infant |
Selected Markets |
Ambroxol HCl |
30mg/5ml (125ml, 250ml Bottles) |
Syr |
Selected Markets |
Amikacin |
500mg/2ml |
Inj.Sol |
International |
Amikacin |
1g/4ml |
Inj.Sol |
International |
ApixabanUnder Development |
2.5mg/tab & 5mg/tab |
F.C.Tabs |
Q4 2023 |
Atorvastatin |
20mg, 40mg |
F.C.Tab |
Selected Markets |
Azithromycin |
500mg/Vial |
Pd.Sol.Inf |
International |
Azithromycin |
250mg, 500mg, 600mg |
F.C.Tab |
Selected Markets |
BrivaracetamUnder Development |
10mg/ml |
Sol.Inf |
Q1 2023 |
BrivaracetamUnder Development |
10mg/ml |
Oral Solution |
Q2 2023 |
Budesonide |
0.025% (Tubx30g, x50g, x100g) |
Cr.Ext.Us |
Selected Markets |
Budesonide |
100mcg/Dose (FLx10ml (200 Doses)) |
Naspr.Sus |
Selected Markets |
Butamirate Citrate |
7.5mg/5ml (200ml Bottle) |
Syr |
International |
Caspofungin |
50mg, 70mg/Vial |
Pd.C.So.In |
International |
Cefotaxime |
1g/Vial (IM, IV) |
Ps.Inj.Sol |
Selected Markets |
Ceftaroline FosamilUnder Development |
600mg/vial |
Pd.C.So.In |
Q3 2024 |
Ceftazidime/ AvibactamUnder Development |
2 g/0.5 g |
Pd.C.So.In |
on going |
Ceftriaxone |
1g/Vial (IM, IV) |
Ps.Inj.Sol |
International |